Skip to main content
Erschienen in: AIDS and Behavior 4/2019

05.12.2018 | Original Paper

HIV Physicians and Chronic Opioid Therapy: It’s Time to Raise the Bar

verfasst von: Jennifer J. Carroll, Jonathan Colasanti, Marlene C. Lira, Carlos del Rio, Jeffrey H. Samet

Erschienen in: AIDS and Behavior | Ausgabe 4/2019

Einloggen, um Zugang zu erhalten

Abstract

Clinical practice that utilizes chronic opioid therapy has been recognized as one major cause of the opioid crisis. Among patients living with HIV, the risks associated with chronic opioid therapy may be complicated by factors such as co-occurring mental health diagnoses, substance use, and economic marginalization. Improving opioid prescribing practices in HIV clinics requires attention to these and other characteristics common to HIV care. In the context of a randomized controlled trial testing an intervention to improve opioid prescribing practices in HIV outpatient clinics, we interviewed physicians about their perspectives on chronic opioid therapy. Overwhelmingly, physicians voiced ambivalence about their own knowledge and comfort with prescription opioids. They raised concerns about the impact of opioid prescribing on patient-provider relationships and the increasing workload associated with prescribing and monitoring patients. In this report, we explore these concerns and propose several strategies for improving clinical care in which chronic opioid therapy is addressed.
Literatur
2.
Zurück zum Zitat Mars SG, Bourgois P, Karandinos G, Montero F, Ciccarone D. “Every ‘never’ I ever said came true”: transitions from opioid pills to heroin injecting. Int J Drug Policy. 2014;25(2):257–66.CrossRefPubMed Mars SG, Bourgois P, Karandinos G, Montero F, Ciccarone D. “Every ‘never’ I ever said came true”: transitions from opioid pills to heroin injecting. Int J Drug Policy. 2014;25(2):257–66.CrossRefPubMed
3.
Zurück zum Zitat Ciccarone D. Editorial for “US Heroin in Transition: Supply Changes, Fentanyl Adulteration and Consequences” IJDP special section. Int J Drug Policy. 2017;46:107–11.CrossRefPubMedPubMedCentral Ciccarone D. Editorial for “US Heroin in Transition: Supply Changes, Fentanyl Adulteration and Consequences” IJDP special section. Int J Drug Policy. 2017;46:107–11.CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat Rummans TA, Burton MC, Dawson NL. How good intentions contributed to bad outcomes: the opioid crisis. Mayo Clin Proc. 2018;93(3):344–50.CrossRefPubMed Rummans TA, Burton MC, Dawson NL. How good intentions contributed to bad outcomes: the opioid crisis. Mayo Clin Proc. 2018;93(3):344–50.CrossRefPubMed
5.
Zurück zum Zitat Uebelacker LA, Weisberg RB, Herman DS, Bailey GL, Pinkston-Camp MM, Stein MD. Chronic pain in HIV-infected patients: relationship to depression, substance use, and mental health and pain treatment. Pain Med Malden Mass. 2015;16(10):1870–81.CrossRef Uebelacker LA, Weisberg RB, Herman DS, Bailey GL, Pinkston-Camp MM, Stein MD. Chronic pain in HIV-infected patients: relationship to depression, substance use, and mental health and pain treatment. Pain Med Malden Mass. 2015;16(10):1870–81.CrossRef
6.
Zurück zum Zitat Colasanti J, Lira MC, Cheng DM, Liebschutz JM, Tsui JI, Forman LS, et al. Chronic opioid therapy in HIV-infected patients: patients’ perspectives on risks. Monitoring and Guidelines: Clin Infect Dis; 2018. Colasanti J, Lira MC, Cheng DM, Liebschutz JM, Tsui JI, Forman LS, et al. Chronic opioid therapy in HIV-infected patients: patients’ perspectives on risks. Monitoring and Guidelines: Clin Infect Dis; 2018.
7.
Zurück zum Zitat Arentoft A, Byrd D, Monzones J, Coulehan K, Fuentes A, Rosario A, et al. Socioeconomic status and neuropsychological functioning: associations in an ethnically diverse HIV+ cohort. Clin Neuropsychol. 2015;29(2):232–54.CrossRefPubMedPubMedCentral Arentoft A, Byrd D, Monzones J, Coulehan K, Fuentes A, Rosario A, et al. Socioeconomic status and neuropsychological functioning: associations in an ethnically diverse HIV+ cohort. Clin Neuropsychol. 2015;29(2):232–54.CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Sionean C, Le BC, Hageman K, Oster AM, Wejnert C, Hess KL, et al. HIV Risk, prevention, and testing behaviors among heterosexuals at increased risk for HIV infection–National HIV Behavioral Surveillance System, 21 U.S. cities, 2010. Morb Mortal Wkly Rep Surveill Summ Wash DC 2002. Morb Mortal Wkly Rep Surveill Summ. 2002;63(14):1–39. Sionean C, Le BC, Hageman K, Oster AM, Wejnert C, Hess KL, et al. HIV Risk, prevention, and testing behaviors among heterosexuals at increased risk for HIV infection–National HIV Behavioral Surveillance System, 21 U.S. cities, 2010. Morb Mortal Wkly Rep Surveill Summ Wash DC 2002. Morb Mortal Wkly Rep Surveill Summ. 2002;63(14):1–39.
9.
Zurück zum Zitat Merlin JS, Walcott M, Kerns R, Bair MJ, Burgio KL, Turan JM. Pain self-management in HIV-infected individuals with chronic pain: a qualitative study. Pain Med Malden Mass. 2015;16(4):706–14.CrossRef Merlin JS, Walcott M, Kerns R, Bair MJ, Burgio KL, Turan JM. Pain self-management in HIV-infected individuals with chronic pain: a qualitative study. Pain Med Malden Mass. 2015;16(4):706–14.CrossRef
10.
Zurück zum Zitat Hansen L, Penko J, Guzman D, Bangsberg DR, Miaskowski C, Kushel MB. Aberrant behaviors with prescription opioids and problem drug use history in a community-based cohort of HIV-infected individuals. J Pain Symptom Manag. 2011;42(6):893–902.CrossRef Hansen L, Penko J, Guzman D, Bangsberg DR, Miaskowski C, Kushel MB. Aberrant behaviors with prescription opioids and problem drug use history in a community-based cohort of HIV-infected individuals. J Pain Symptom Manag. 2011;42(6):893–902.CrossRef
11.
Zurück zum Zitat Namisango E, Harding R, Atuhaire L, Ddungu H, Katabira E, Muwanika FR, et al. Pain among ambulatory HIV/AIDS patients: multicenter study of prevalence, intensity, associated factors, and effect. J Pain Off J Am Pain Soc. 2012;13(7):704–13.CrossRef Namisango E, Harding R, Atuhaire L, Ddungu H, Katabira E, Muwanika FR, et al. Pain among ambulatory HIV/AIDS patients: multicenter study of prevalence, intensity, associated factors, and effect. J Pain Off J Am Pain Soc. 2012;13(7):704–13.CrossRef
12.
Zurück zum Zitat Merlin JS, Zinski A, Norton WE, Ritchie CS, Saag MS, Mugavero MJ, et al. A conceptual framework for understanding chronic pain in patients with HIV. Pain Pract. 2014;14(3):207–16.CrossRefPubMed Merlin JS, Zinski A, Norton WE, Ritchie CS, Saag MS, Mugavero MJ, et al. A conceptual framework for understanding chronic pain in patients with HIV. Pain Pract. 2014;14(3):207–16.CrossRefPubMed
13.
Zurück zum Zitat Lum PJ, Little S, Botsko M, Hersh D, Thawley RE, Egan JE, et al. Opioid-prescribing practices and provider confidence recognizing opioid analgesic abuse in HIV primary care settings. J Acquir Immune Defic Syndr. 2011;56(1):S91–7.CrossRefPubMed Lum PJ, Little S, Botsko M, Hersh D, Thawley RE, Egan JE, et al. Opioid-prescribing practices and provider confidence recognizing opioid analgesic abuse in HIV primary care settings. J Acquir Immune Defic Syndr. 2011;56(1):S91–7.CrossRefPubMed
14.
Zurück zum Zitat Tsui JI, Walley AY, Lira MC, Chaisson CE, Forman LS, Colasanti JA, et al. Opioid Prescribing Attitudes and Risk Mitigation Practices in Two HIV Clinics. Conference presentation presented at: Annual Meeting of the College on Problems of Drug Dependence; 2017; Montreal. Tsui JI, Walley AY, Lira MC, Chaisson CE, Forman LS, Colasanti JA, et al. Opioid Prescribing Attitudes and Risk Mitigation Practices in Two HIV Clinics. Conference presentation presented at: Annual Meeting of the College on Problems of Drug Dependence; 2017; Montreal.
15.
Zurück zum Zitat Liebschutz JM, Xuan Z, Shanahan CW, LaRochelle M, Keosaian J, Beers D, et al. Improving adherence to long-term opioid therapy guidelines to reduce opioid misuse in primary care: a cluster-randomized clinical trial. JAMA Intern Med. 2017. Liebschutz JM, Xuan Z, Shanahan CW, LaRochelle M, Keosaian J, Beers D, et al. Improving adherence to long-term opioid therapy guidelines to reduce opioid misuse in primary care: a cluster-randomized clinical trial. JAMA Intern Med. 2017.
16.
Zurück zum Zitat Bauer SR, Katz MH. Going beyond guideline-concordant opioid therapy to improve patient safety. JAMA Intern Med. 2017;177(9):1272.CrossRefPubMed Bauer SR, Katz MH. Going beyond guideline-concordant opioid therapy to improve patient safety. JAMA Intern Med. 2017;177(9):1272.CrossRefPubMed
17.
18.
Zurück zum Zitat Avorn J. Academic detailing: “Marketing” the best evidence to clinicians. JAMA. 2017;317(4):361–2.CrossRefPubMed Avorn J. Academic detailing: “Marketing” the best evidence to clinicians. JAMA. 2017;317(4):361–2.CrossRefPubMed
19.
Zurück zum Zitat Bruce RD, Merlin J, Lum PJ, Ahmed E, Alexander C, Corbett AH, et al. 2017 HIVMA of IDSA clinical practice guideline for the management of chronic pain in patients living with HIV. Clin Infect Dis. 2017;65(10):e1–37.CrossRefPubMedPubMedCentral Bruce RD, Merlin J, Lum PJ, Ahmed E, Alexander C, Corbett AH, et al. 2017 HIVMA of IDSA clinical practice guideline for the management of chronic pain in patients living with HIV. Clin Infect Dis. 2017;65(10):e1–37.CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat Katzman JG, Galloway K, Olivas C, McCoy-Stafford K, Duhigg D, Comerci G, et al. Expanding health care access through education: dissemination and implementation of the ECHO model. Mil Med. 2016;181(3):227–35.CrossRefPubMed Katzman JG, Galloway K, Olivas C, McCoy-Stafford K, Duhigg D, Comerci G, et al. Expanding health care access through education: dissemination and implementation of the ECHO model. Mil Med. 2016;181(3):227–35.CrossRefPubMed
21.
Zurück zum Zitat Weinstein RS, Lopez AM, Joseph BA, Erps KA, Holcomb M, Barker GP, et al. Telemedicine, telehealth, and mobile health applications that work: opportunities and barriers. Am J Med. 2014;127(3):183–7.CrossRefPubMed Weinstein RS, Lopez AM, Joseph BA, Erps KA, Holcomb M, Barker GP, et al. Telemedicine, telehealth, and mobile health applications that work: opportunities and barriers. Am J Med. 2014;127(3):183–7.CrossRefPubMed
22.
Zurück zum Zitat Starrels JL, Peyser D, Haughton L, Fox A, Merlin JS, Arnsten JH, et al. When human immunodeficiency virus (HIV) treatment goals conflict with guideline-based opioid prescribing: a qualitative study of HIV treatment providers. Subst Abuse. 2016;37(1):148–53.CrossRef Starrels JL, Peyser D, Haughton L, Fox A, Merlin JS, Arnsten JH, et al. When human immunodeficiency virus (HIV) treatment goals conflict with guideline-based opioid prescribing: a qualitative study of HIV treatment providers. Subst Abuse. 2016;37(1):148–53.CrossRef
Metadaten
Titel
HIV Physicians and Chronic Opioid Therapy: It’s Time to Raise the Bar
verfasst von
Jennifer J. Carroll
Jonathan Colasanti
Marlene C. Lira
Carlos del Rio
Jeffrey H. Samet
Publikationsdatum
05.12.2018
Verlag
Springer US
Erschienen in
AIDS and Behavior / Ausgabe 4/2019
Print ISSN: 1090-7165
Elektronische ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-018-2356-2

Weitere Artikel der Ausgabe 4/2019

AIDS and Behavior 4/2019 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.